JMJD5 Inhibits Lung Cancer Progression by Regulating Glucose Metabolism through the p53/TIGAR Pathway

Scientists discovered that knockdown of jumonji C domain-containing protein 5 (JMJD5) significantly enhanced TIGAR expression in p53 wild-type NSCLC cells, which could further suppress glycolysis and promote the pentose phosphate pathway.